Page last updated: 2024-08-23

razoxane and aclarubicin

razoxane has been researched along with aclarubicin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jensen, PB; Sehested, M1
Anderson, H; Roberge, M1
Allan, WP; Creighton, AM; Fattman, CL; Hasinoff, BB; Kuschak, TI; Thampatty, P; Yalowich, JC1
Hansen, HF; Jensen, LH; Jensen, PB; Nitiss, JL; Rothenborg-Jensen, L; Schmidt, G; Sehested, M; Wessel, I1

Other Studies

4 other study(ies) available for razoxane and aclarubicin

ArticleYear
Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle.
    Biochemical pharmacology, 1996, Apr-12, Volume: 51, Issue:7

    Topics: Aclarubicin; Blotting, Western; Diterpenes; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Razoxane; Tumor Cells, Cultured

1996
Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1996, Volume: 7, Issue:1

    Topics: Aclarubicin; Alkenes; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Cycle Proteins; Cell Line; Chromosomes; Cricetinae; DNA-Binding Proteins; Enzyme Inhibitors; Etoposide; G2 Phase; Guanine Nucleotide Exchange Factors; Kidney; Mitosis; Nuclear Proteins; Okadaic Acid; Phosphoprotein Phosphatases; Polyenes; Pyrones; Razoxane; Temperature; Thiobarbiturates; Topoisomerase II Inhibitors

1996
Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II.
    Biochemical pharmacology, 1997, Jun-15, Volume: 53, Issue:12

    Topics: Aclarubicin; Animals; CHO Cells; Cricetinae; DNA Topoisomerases, Type II; Drug Resistance; Ethylenediamines; Etoposide; Glycine; Mutation; Razoxane; Thiobarbiturates; Topoisomerase II Inhibitors; Verapamil

1997
Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
    Anti-cancer drug design, 2001, Volume: 16, Issue:6

    Topics: Aclarubicin; Acridines; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport, Active; Cell Survival; Cross-Linking Reagents; DNA; DNA Damage; DNA Topoisomerases, Type II; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; In Vitro Techniques; Mutation; Podophyllotoxin; Polymerase Chain Reaction; Razoxane; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured

2001